Balaxi Pharmaceuticals Growth Remains Robust on Back of Geographical Expansions
Revenue growth of 40.3% on YoY basis, with operating…
Balaxi Pharmaceuticals Limited Conducts Groundbreaking Ceremony for its Upcoming ₹ 85 Cr. State-of-the-Art Manufacturing Facility in Hyderabad
Commissioning of the US-FDA, EU-GMP, WHO-Geneva Compliant Pharmaceutical Formulation…
Balaxi Pharmaceuticals Delivers Strong Growth in Q2 FY23
Hyderabad, Telangana, India Revenue up 23%, Profit After Tax…
Balaxi Pharmaceuticals Reports Continued Solid Growth in Q1 FY23
Hyderabad, Telangana, India Revenue grows 42% in Q1FY23. …
